Biotalys
在场
Biotalys 是一家在股票代码 BTLS (NL) 下上市的公司。
高管
查看带有其 15 名主要高管的组织结构图
Biotalys 搜索最多的简介
- Kevin Helash, Chief Executive Officer and Director
- Johan Cardoen, Non-Executive Director
- Michiel van Lookeren, Non-Executive Director
高管在Biotalys变化
- Kamal El Mernissi已作为Chief Business Development Officer加入公司 (新闻发布的2024十月18号).
创建提醒
跟踪 Biotalys 的高管变动
生物技术
Biotalys 拥有 2,345 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Genus (联合王国)。
Popular M&A news in 生物技术
- Latigo Biotherapeutics 刚刚宣布为 150 筹款数百万美元。 (公布2025三月24号).
- AlloVir and Kalaris Therapeutics have announced they will merge (公布2025三月24号)..
- Purespring Therapeutics 刚刚宣布为 105 筹款数百万美元。 (公布2025三月14号).
生物技术 行业的其他推荐联系人
消息
Biotalys 的最新新闻稿
- Invitation to the ordinary general shareholders meeting | Biotalys
- Biotalys Reports Full-Year 2024 Financial Results and Business Highlights | Biotalys
- Biotalys Achieves Strong Results in Field Trials with Second Biofungicide | Biotalys
- Information on the total number of voting rights and shares | Biotalys
- Biotalys Provides Regulatory Review Update on EVOCA | Biotalys
- Publication of transparency notifications | Biotalys
- Biotalys Expands R&D Pipeline with New Biofungicide Program | Biotalys
- Biotalys Granted Patents for EVOCA in Both Europe and the United States | Biotalys
- Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands | Biotalys
- Biotalys Notice of Half Year 2024 Results and Business Highlights | Biotalys
- View more press releases Close
